FDA News

Featured Article
Antiarrhythmic Agent Recalled
The FDA has issued a recall for a prescription antiarrhythmic used to treat heart rhythm issues.
Additional Antacids Pulled Over NMDA Contamination
AvKARE Inc. and AuroMedics Pharma have joined a number of companies voluntarily recalling ranitidine products because of contamination with the probable human carcinogen N-Nitrosodimethylamine.
Liquid Pain Medicine Recalled in Three States
Preferred Pharmaceuticals Inc. is voluntarily recalling several lots of prescription ibuprofen oral suspension.

Newsfeed

Antiarrhythmic Agent Recalled
Additional Antacids Pulled Over NMDA Contamination
Liquid Pain Medicine Recalled in Three States
FDA Probes Diabetes Drug Metformin for Carcinogen NDMA
FDA Declines to Approve Enzyvant Regenerative Therapy on Manufacturing Concerns
FDA Targets Firms Illegally Selling Cannabidiol Products
Seizure Med Recalled
Antiviral Drug Recalled
View More
Back to Top